Related by context. All words. (Click for frequent words.) 62 autonomic dysfunction 61 glomerular filtration 61 artery stenosis 61 postoperative complication 61 HeFH 60 systolic dysfunction 60 neurodevelopmental impairment 60 bronchial hyperresponsiveness 60 aminotransferase 60 elevated triglyceride levels 60 seropositivity 60 CP CPPS 60 glycated hemoglobin levels 60 nonischemic 60 albumin excretion rate 60 HIV HCV coinfected 59 GH deficiency 59 malignant neoplasm 59 chorioamnionitis 59 albumin excretion 59 heterozygotes 59 isolated systolic hypertension 59 acetabular dysplasia 59 colorectal adenoma 59 mIU L 59 thyrotropin 59 hepatorenal syndrome 59 CC genotype 59 arterial thromboembolic events 59 prolonged QT interval 59 carotid stenosis 59 fructose intolerance 59 overt hypothyroidism 59 latent celiac disease 59 gait disturbances 59 nondiabetic patients 59 GBA mutations 59 hypophosphatemia 59 elevated IOP 58 triglyceride concentrations 58 morphometric vertebral fractures 58 subclinical hypothyroidism 58 elevated ALT 58 hyperhomocysteinemia 58 sensory neuropathy 58 alpha1 antitrypsin deficiency 58 multivariable adjusted 58 thromboembolic complications 58 NNT = 58 cerebral vasospasm 58 hyperparathyroidism 58 mutated K ras 58 atrioventricular block 58 symptomatic intracranial hemorrhage 57 NYHA functional class 57 CTEPH 57 Aortic stenosis 57 airway hyper responsiveness 57 homozygous familial hypercholesterolemia 57 familial hypercholesterolemia 57 elevated fasting glucose 57 advanced adenoma 57 nondiabetics 57 nonvertebral fracture 57 obstructive CAD 57 metabolic acidosis 57 moderate renal impairment 57 spirometric 57 testicular tumors 57 haematologic 57 hypercholesterolaemia 57 atrophic gastritis 57 T2DM 57 gestational diabetes mellitus GDM 57 acromegalic patients 57 cardiac malformations 57 syncopal episodes 57 BENICAR HCT 57 apolipoprotein E4 57 LV dysfunction 57 hyperprolactinemia 57 heFH 57 oligohydramnios 57 biochemical relapse 57 smoldering multiple myeloma 57 transaminase elevations 57 octreotide LAR 57 Papillary 57 cerebral infarction 57 HER2 expression 57 PHPT 57 homocysteine concentrations 57 bronchoalveolar lavage 57 serum lipid levels 57 enterocolitis 57 nonfasting triglyceride levels 57 chronic hepatitis cirrhosis 57 isoprostane 57 left ventricular systolic 57 ALT elevation 57 euthyroid 57 serum aminotransferase levels 57 serum BDNF 57 eNO 57 poor metabolizers 57 leptin deficiency 57 Stent thrombosis 57 subclinical atherosclerosis 57 PAOD 57 neurologic symptoms 57 ejection fractions 56 SGPT 56 improves glycemic 56 visceral adiposity 56 pamidronate 56 creatine kinase CK 56 diastolic function 56 extrapyramidal symptoms 56 subclinical hyperthyroidism 56 hyperoxia 56 homozygotes 56 Infusion Reactions Severe 56 diabetic kidney 56 neurological abnormalities 56 #mmHg [001] 56 cranial irradiation 56 salmeterol fluticasone 56 serum IGF 56 NIHSS score 56 adenoma recurrence 56 HOMA IR 56 silent ischemia 56 neutropenic sepsis 56 mL/min/#.# m 2 56 β blockers 56 bioavailable testosterone 56 nontraumatic 56 Subgroup analysis 56 hepatocellular carcinomas 56 triiodothyronine 56 INCB# [003] 56 #ng/ml 56 ximelagatran 56 brain lesions 56 nitrotyrosine 56 dyssynchrony 56 coronary stenosis 56 Clinically significant 56 aortic root replacement 56 neoplasias 56 left ventricular diastolic 56 leukocyte counts 56 adrenocorticotropic hormone 56 mild renal insufficiency 56 Avandia Actos 56 serum LDL cholesterol 56 TNF antagonist 56 coagulopathy 56 neovascular 56 alpha1 56 abdominal adiposity 56 external genital lesions 56 thyrotropin levels 56 quetiapine Seroquel 56 adiponectin concentrations 56 parous women 56 pancreatic insufficiency 56 aminotransferases 56 symptomatic VTE 56 Skin sterol 56 serum urate levels 56 echocardiographic parameters 56 hippocampal atrophy 56 lipid elevations 56 warfarin sodium 56 postoperative delirium 56 Heavy menstrual bleeding 56 thrombocytopenic 56 HbA1C levels 56 growth hormone secretion 55 bronchopulmonary dysplasia 55 troponin T 55 myocardial fibrosis 55 microangiopathy 55 juvenile idiopathic arthritis JIA 55 QTcF 55 lymphatic cancers 55 hematological parameters 55 intact parathyroid hormone 55 Insulin sensitivity 55 Cardiorespiratory fitness 55 Ejection Fraction 55 glycaemia 55 #OHD 55 Index CDAI 55 elevated LDH 55 Adenomas 55 hyperlipemia 55 APOE e4 55 aspartate aminotransferase 55 serum triglyceride levels 55 abacavir Ziagen 55 corticosteroid dose 55 glycosylated hemoglobin HbA1c 55 plasminogen activator inhibitor 55 Vidaza azacitidine 55 anemia hemoglobin 55 Vernakalant 55 T1DM 55 leukocyte count 55 severe periodontitis 55 recurrent UTI 55 CVD mortality 55 receiving XGEVA 55 postoperative infection 55 LV ejection fraction 55 BMPR2 55 hyperreflexia 55 intracranial hemorrhage ICH 55 prolactin levels 55 gastric adenocarcinoma 55 serum estradiol 55 serum parathyroid hormone 55 systemic hypotension 55 Hyperlipidemia 55 akinesia 55 receptor inhibitor 55 Hypotension 55 serum phosphate 55 ARCALYST ® 55 VaD 55 tibolone 55 G6PD deficiency 55 plasma fibrinogen 55 MMSE scores 55 perioperatively 55 Tasigna prolongs 55 iNO 55 plasma homocysteine 55 Postoperative complications 55 carotid artery blockage 55 IDDM 55 neurologic complications 55 nonvertebral fractures 55 gallstone disease 55 serum uric acid 55 neutrophil counts 55 Hypertrophy 55 timepoints 55 transfusion syndrome 55 preterm neonates 55 carotid IMT 55 insulin resistance syndrome 55 cortisol secretion 55 endothelial activation 55 elevated bilirubin 55 DAS# CRP 55 leucopenia 55 ischemia driven 55 recurrent wheezing 55 null mice 55 polyp recurrence 55 serum sodium levels 55 vaso occlusive crisis 55 baroreceptor 54 rFVIIa 54 complete cytogenetic response 54 nondiabetic subjects 54 multivariate Cox 54 serum PTH 54 neutropaenia 54 chronic thromboembolic pulmonary 54 HIV coinfected 54 MMSE score 54 baseline HbA1c 54 mitoxantrone plus 54 haemorrhagic stroke 54 decompensated heart failure 54 baseline serum creatinine 54 proliferative diabetic retinopathy 54 thromboembolism 54 adiponectin levels 54 CIMZIA TM certolizumab pegol 54 Plasma concentrations 54 induce orthostatic hypotension 54 steroid dexamethasone 54 variant alleles 54 regression coefficient 54 HoFH 54 sinus node dysfunction 54 unresectable HCC 54 paresthesias 54 RAS mutations 54 resynchronization therapy 54 macrovascular disease 54 LAB CGRP 54 sulfonylurea metformin 54 tryptophan hydroxylase 54 lymphocytosis 54 valvular heart disease 54 MULTAQ 54 ß blockers 54 onset diabetes mellitus 54 QRS duration 54 kallikrein 54 thyroid hormone levels 54 adrenalectomy 54 multivariate adjustment 54 multivariable analysis 54 serum homocysteine 54 myelodysplastic myeloproliferative diseases 54 Orthostatic hypotension 54 normotensive 54 extrapyramidal 54 perioperative complications 54 binary restenosis 54 cardiac dysfunction 54 postoperative atrial fibrillation 54 alanine aminotransferase 54 tranylcypromine 54 asymptomatic carotid stenosis 54 normal ULN 54 hyperlipidaemia 54 IFN beta 54 PPCM 54 serum calcium levels 54 seropositive patients 54 hepatic cirrhosis 54 exhaled nitric oxide 54 hypocalcaemia 54 riociguat 54 bacteriuria 54 Legg Calvé Perthes disease 54 elevated triglycerides 54 pretest probability 54 overactive bladder symptoms 54 protein excretion 54 Genetic mutation 54 Cognitive impairment 54 familial hypercholesterolemia FH 54 serum cortisol 54 cardiac repolarization 54 exhaled NO 54 polytherapy 54 prolactin elevation 54 Intravitreal 54 fasting plasma 54 multivessel disease 54 beta blocker therapy 54 torsade de pointes 54 alanine aminotransferase ALT 54 parkinsonism 54 aminotransferase levels 54 Serious adverse reactions 54 lactate dehydrogenase LDH 54 hemoglobin A1c levels 54 APOC3 54 muscle hypertrophy 54 leiomyomas 54 Soy isoflavones 54 pulmonary arterial 54 plasma triglycerides 54 autoregulation 54 phase IIb study 54 intracerebral haemorrhage 54 cystic fibrosis chronic pancreatitis 54 oxycodone CR 54 aspartate aminotransferase AST 54 PSADT 54 antibody titer 54 Hyperparathyroidism 54 hematopoietic cancers 54 plasma leptin 54 GRNCM1 54 interstitial pneumonia 54 COPD exacerbation 54 #ß 54 Erythropoietic therapies may 54 HDL2 54 TIMP 1 54 enzyme elevations 54 esotropia 54 advanced adenomas 54 LPS induced 54 plasma cortisol 54 fluvastatin 54 PRADAXA #mg 54 hepatic enzymes 54 variant angina 54 graft occlusion 54 transaminase levels 53 intima media thickness 53 retrograde ejaculation 53 gestational hypertension 53 myocardial infarct size 53 serum vitamin D 53 mU liter 53 nadolol 53 Ventricular Tachycardia 53 PLMs 53 AST ALT 53 hypertension diabetes mellitus 53 lactate dehydrogenase 53 artery calcification 53 paroxysmal AF 53 thromboembolic 53 Lp PLA 2 53 tissue oxygenation 53 handgrip strength 53 vasogenic edema 53 PASI scores 53 elevated transaminases 53 endometrial hyperplasia 53 Thrombocytopenia 53 chronic granulomatous disease 53 ventricular dilation 53 HbA 1c levels 53 impaired glucose metabolism 53 sustained ventricular tachycardia 53 IOP lowering 53 venous thromboembolic disease 53 Magnesium deficiency 53 thrombocytosis 53 gadobutrol 53 tipranavir r 53 antiphospholipid antibodies 53 ductal breast cancer 53 serum triglycerides 53 femoral neck BMD 53 elevated homocysteine 53 oxygen desaturation 53 salivary flow 53 adjunctive placebo 53 inhaled corticosteroids ICS 53 CI #.#-#.# [001] 53 cardiac perfusion 53 depressive symptomatology 53 extracapsular extension 53 elevated hsCRP 53 Proteinuria 53 reintubation 53 c reactive protein 53 pyelonephritis 53 severe exacerbations 53 transferrin saturation 53 benazepril 53 systemic corticosteroid 53 pentoxifylline 53 receptor antagonism 53 ALT elevations 53 tHcy 53 parkinsonian 53 dysmenorrhoea 53 afterload 53 MS relapses 53 pT3 53 hypercholesterolemic patients 53 cough dyspnea 53 thrombocytopenic patients 53 elevated uric acid 53 pulmonary dysfunction 53 nicardipine 53 overt nephropathy 53 transaminases 53 hypercoagulable 53 MELAS 53 serum concentrations 53 hippocampal volume 53 Prehypertension 53 selective phosphodiesterase 53 Hb A1c 53 Vitamin B# deficiency 53 relapsed MM 53 nmol 53 Univariate analysis 53 arteritis 53 serum retinol 53 autosomal recessive disorder 53 folate deficiency 53 GI motility 53 normothermic 53 pulmonary hypoplasia 53 anemia neutropenia 53 inotropic 53 dysglycemia 53 fibrin deposition 53 creatine kinase MB 53 thyroid stimulating hormone TSH 53 mmol l 53 ischaemia 53 Hp2 2 53 mmHg diastolic 53 invasive candidiasis 53 % Confidence Interval 53 sinus bradycardia 53 neurodevelopmental outcomes 53 hepatic enzyme 53 serum bilirubin 53 osteosarcomas 53 noncardiovascular mortality 53 achieved ACR# 53 fractional shortening 53 nondiabetic 53 perimenopausal women 53 paricalcitol 53 HDL LDL ratio 53 Complication rates 53 hyperbilirubinemia 53 % CI #.#-#.# [007] 53 intermittent claudication 53 myocardial reperfusion 53 rebleeding 53 shorter telomere length 53 Sjögren syndrome 53 Calcium intake 53 metabolic parameters 53 Interferon beta 1b 53 preserved ejection fraction 53 hyperalgesia 53 CrCl 53 baroreflex 53 Serum concentrations 53 waist circumference WC 53 hyperglycaemia 53 lumbar spine bone 53 oral antidiabetes 53 Hazard Ratio = 53 hepatic glucose production 53 hypoglycemic episodes 53 nitrosothiols 53 serum TSH 53 TEAEs 53 plasma lipids 53 Apolipoprotein B 53 ADCS CGIC 53 Thyroid hormone 53 creatine kinase 53 preeclamptic 53 metastatic malignant 53 mcg QD 53 retransplantation 53 x ULN 53 SGOT 53 ATACAND 53 hypovitaminosis D 53 medulloblastoma tumors 53 symptomatic intracranial 53 atopic 53 hydroxyvitamin D levels 53 leptin deficient mice 53 nonmelanoma skin cancers 53 neurodevelopmental outcome 52 μg dl 52 hypokalemia hypomagnesemia 52 Hb A1C 52 p = NS 52 posttransplant 52 nadroparin 52 ALT flares 52 hypoxemia 52 tryptase 52 CK MB 52 Diabetic neuropathy 52 Atrasentan 52 opioid naïve 52 Sarcopenia 52 RhuDex R 52 somatic symptoms 52 dyspnoea 52 triacylglycerol concentrations 52 atherogenic dyslipidemia 52 EDSS scores 52 steroid refractory ulcerative 52 Operative mortality 52 BMI ≥ 52 tachyarrhythmias 52 μg kg 52 nonobese 52 fulminant hepatic failure 52 myocardial infarctions MIs 52 Stage IIIb 52 MetS 52 nonfatal MI 52 recurrent DVT 52 intraabdominal 52 frequent awakenings 52 Tesofensine 52 deep venous thromboses 52 folate concentrations 52 serum cholesterol 52 plasma homocysteine levels 52 abnormal lipid levels 52 arterial oxygen saturation 52 pg ml 52 triglyceride concentration 52 hematologic abnormalities 52 umbilical artery 52 subcutaneous adipose tissue 52 carcinoids 52 dosing cohort 52 μg L 52 chills fever headache 52 impaired cognition 52 fasting glucose levels 52 undetectable viral 52 Hepatotoxicity 52 bone marrow reticulin deposition 52 dose Iluvien 52 urine NGAL 52 confidence interval #.#-#.# 52 postoperative AF 52 Lumbar spine 52 noncardiac 52 hypovolemia 52 supraventricular arrhythmias 52 TT genotype 52 Chronic myeloid leukemia 52 hip BMD 52 arterial thromboembolism 52 nitrofurantoin 52 sitosterol 52 thrombocytopenia neutropenia 52 aminotransferase ALT 52 SUVmax 52 prospectively stratified 52 carotid atherosclerosis 52 achieved CCyR 52 Creatinine 52 guanfacine extended release 52 low dose Iluvien 52 lobular breast cancer 52 immune thrombocytopenic purpura ITP 52 intermittent exotropia 52 gastrointestinal perforation 52 Elevated triglycerides 52 predisposing factor 52 collagenous colitis 52 cerebral oxygenation 52 urine albumin 52 seminal vesicle invasion 52 cerebral infarctions 52 invasive aspergillosis 52 clomipramine 52 rhinoconjunctivitis 52 Acute Myeloid Leukaemia AML 52 clinically meaningful improvement 52 VT VF 52 osteopenic 52 isoenzyme 52 intracerebral hemorrhages 52 mL/min/#.# m2 52 syncope fainting 52 ViaDerm hPTH #-# 52 nerve conduction velocity 52 SCIg 52 hsCRP levels 52 hypervolemic 52 elevated serum creatinine 52 patientswith 52 subclinical inflammation 52 orofacial clefts 52 postoperative mortality 52 recurrent VTE 52 macroalbuminuria 52 LymphoStat B belimumab 52 vasopressor 52 serum albumin 52 comorbid illnesses 52 serum urate 52 leptin concentrations 52 NPH insulin 52 hemoglobin A1c HbA1c 52 sitaxsentan 52 salmeterol fluticasone propionate 52 alpha1 antitrypsin AAT deficiency 52 idiopathic thrombocytopenic purpura ITP 52 chromium supplementation 52 oral antidiabetic medication 52 type2 diabetes 52 central adiposity 52 ACE Inhibitor 52 Preterm infants 52 EDSS score 52 cryptorchidism 52 clazosentan 52 Hemoglobin A1c 52 loop diuretics 52 PSA nadir 52 Xelox 52 fasting insulin 52 lumbar spine BMD 52 left ventricular LV 52 varus deformity 52 containing abacavir 52 silent myocardial ischemia 52 maximal aerobic capacity 52 cerebrovascular accidents 52 pulmonary exacerbations 52 glycated hemoglobin HbA1c 52 5-FU/LV 52 Hypoglycaemia 52 renal artery stenting 52 apolipoprotein B 52 segment binary restenosis 52 cardio respiratory fitness 52 rectal temperature 52 renal cysts 52 chronic venous insufficiency 52 SGRQ 52 insulin glulisine 52 neutropenia febrile neutropenia 52 cytomegalovirus infection 51 delayed gastric emptying 51 exudative AMD 51 beta carotene supplementation 51 viral titers 51 conduction abnormalities 51 lispro 51 nonfasting triglycerides 51 postprocedure 51 insulin resistance precursor 51 glucose insulin 51 Daytime sleepiness 51 thyroid deficiency 51 prednisone prednisolone 51 Toxicities 51 prolonged QT intervals 51 Postoperatively 51 atopic disease 51 Crohn Disease Activity 51 constipation predominant IBS 51 D dimer 51 #mg/dl 51 intraocular pressure IOP 51 BARACLUDE ® 51 lupus anticoagulant 51 sUA 51 headache abdominal pain 51 renal toxicity 51 beta3 51 HIV lipodystrophy 51 posterior vitreous detachment 51 moderately emetogenic 51 urinary albumin excretion 51 malignant ascites 51 acarbose 51 serum ferritin 51 exocrine pancreatic insufficiency EPI 51 hemoglobin Hb 51 gm dl 51 undetectable HBV DNA 51 olmesartan 51 genital ulcers 51 gastric cardia 51 antithymocyte globulin 51 squamous cell lung cancer 51 Fasting glucose 51 carotid plaques 51 nonhuman primate model 51 N telopeptide 51 tumor xenograft models 51 Drug Eluting Stent System 51 androgen excess 51 dopaminergic therapy 51 blood glucose concentrations 51 Claudication 51 hemoglobin concentrations 51 CETi 51 Dacogen decitabine 51 lumbar lordosis 51 Impaired glucose tolerance 51 bisoprolol 51 acetonide FA 51 alkalosis 51 daily subcutaneous injections 51 galactosemia 51 RAS blockers 51 confidence intervals CIs 51 systolic hypertension 51 serum testosterone 51 Familial hypercholesterolemia 51 Myocardial infarction 51 ventricular enlargement 51 lymphocyte count 51 parasitaemia 51 Folate deficiency 51 #.#mmol L [002] 51 serum folate 51 untreated celiac disease 51 haloperidol Haldol 51 -#.# ± [002] 51 abnormal ejaculation 51 rimonabant #mg 51 mIU ml 51 Genentech Rituxan 51 urolithiasis 51 flutamide 51 elevated troponin 51 edifoligide 51 #OHD levels 51 generalized edema 51 blood clotting protein 51 lowering blood glucose 51 nephrotoxicity 51 E selectin 51 β blocker 51 Valproic acid 51 comorbid disorders 51 atorvastatin #mg 51 patellofemoral pain syndrome 51 tesofensine 51 hyperresponsiveness 51 VLBW infants 51 CLA supplementation 51 Testosterone deficiency 51 μg liter 51 creatine phosphokinase 51 nmol l 51 Fibromyalgia Impact Questionnaire 51 severe hypoglycemic episodes 51 hyperammonemia 51 imipramine Tofranil 51 apneic episodes 51 abdominal circumference 51 % CI #.#-#.# [003] 51 achieved statistical significance 51 obstructive apnea 51 Initiate Phase 51 hypercalcemia 51 visceral adipose tissue 51 endocrinologic 51 impaired endothelial 51 lowest tertile 51 NIHSS 51 Serum creatinine 51 Angiotensin Therapeutic Vaccine 51 inflammatory biomarkers 51 amenorrhoea 51 fosamprenavir 51 ventricular remodeling 51 HBeAg 51 MCyR 51 Symptom severity 51 Viread Emtriva Sustiva 51 QTc intervals 51 recurrent atrial fibrillation 51 LDL triglycerides 51 hemodilution 51 allergic eczema 51 eosinophil count 51 intravitreal injections 51 μmol L 51 metabolic abnormalities 51 hyperinsulinemia 51 hypokalemia 51 methacholine challenge 51 induced anemia 51 obstructive lung 51 thyroxine 51 urate lowering therapy 51 T2 lesion volume 51 fatal pulmonary embolism 51 Cilostazol 51 diastolic pressures 51 hsCRP 51 fasting triglyceride levels 51 adrenal insufficiency 51 abdominal distension 51 #mm Hg 51 idiopathic membranous nephropathy 51 intratympanic 51 psoriasis Crohn disease 51 non fasting triglycerides 50 PPAR agonist 50 endophthalmitis 50 VTEs 50 metabolizing enzyme 50 Sudhir Agrawal D.Phil 50 urate levels 50 gallstone formation 50 detemir 50 statins cholesterol lowering 50 carisbamate 50 inversely associated 50 preterm newborns 50 fetal malformations 50 acute mania 50 Triglyceride levels 50 Homocysteine levels 50 biventricular pacing 50 cytopenias 50 ventricular tachycardia VT 50 statin monotherapy 50 μg d 50 cancerous colon polyps 50 PaO 2 50 artery thickening 50 palmar plantar 50 NNRTI resistance 50 diastolic blood pressures 50 corticotrophin releasing hormone 50 haemorrhagic strokes 50 POAG 50 umol L 50 glulisine 50 milliliters mL 50 serum creatinine levels 50 myelogenous leukemia 50 UCB Cimzia 50 pmol L 50 corticosteroid therapy 50 parasitemia 50 urinary cadmium 50 ml min 50 mycophenolate mofetil MMF 50 gastrin analogue TT 50 psychiatric comorbidities 50 detrusor 50 neurodevelopmental disability 50 Phenylketonuria PKU 50 DepoCyt 50 hepatic liver 50 mineral density 50 receiving prophylactic anticoagulation 50 rheumatic arthritis 50 d4T stavudine Zerit 50 symptomatic GERD 50 density lipoprotein cholesterol HDL 50 Sleep disturbances 50 Timed Walk 50 ventricular dyssynchrony 50 metabolic disturbances 50 triglyceride TG 50 prescribed statins 50 mmHg systolic 50 cardiomyopathy weakening 50 atypical ductal hyperplasia 50 nasopharyngitis headache 50 irregular quivering 50 Roflumilast 50 serum leptin 50 ICD shocks 50 elevated LDL cholesterol 50 undergoing peritoneal dialysis 50 % CI #.#-#.# [001] 50 conditional logistic regression 50 Morquio 50 serum sodium 50 mecasermin rDNA origin 50 TMP SMX 50 renal impairment 50 dose dependently 50 tertile 50 Coronary CTA 50 fasting triglycerides 50 aminophylline 50 corticosteroid dexamethasone 50 LVSD 50 mmol liter 50 intestinal polyps 50 mcg kg REBETOL 50 maximal doses 50 mcg BID 50 Recombinant interferon alpha 50 #Gy 50 systolic function 50 orthostatic 50 elevated lipase 50 flow mediated dilation 50 Hippocampal 50 systolic diastolic 50 gross hematuria 50 symptomatic hypotension 50 QTc 50 Retreatment 50 oxygen saturations 50 ventricular tachyarrhythmia 50 thiazide 50 #.#ng/ml 50 highest tertile 50 Gattex 50 nocturnal hypoglycaemia 50 #mg/day [001] 50 Fasting blood glucose 50 improves insulin sensitivity 50 multicenter placebo controlled 50 Ejection fraction 50 NIASPAN 50 clinically evaluable patients 50 suboptimal adherence 50 supraventricular 50 elevated creatinine 50 anastomotic leak 50 GSNO 50 conventional DMARDs 50 venlafaxine Effexor 50 preoperative PSA 50 abdominal irradiation 50 dyskeratosis congenita